Rankings
▼
Calendar
SION Q4 2025 Earnings — Sionna Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SION
Sionna Therapeutics, Inc.
$2B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$247,000
Operating Income
-$24M
Net Income
-$20M
EPS (Diluted)
$-0.46
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$17M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$326M
Total Liabilities
$19M
Stockholders' Equity
$307M
Cash & Equivalents
$58M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$247,000
$0
—
Operating Income
-$24M
-$18M
-30.2%
Net Income
-$20M
-$16M
-29.0%
← FY 2025
All Quarters